In this article, we will discuss the 5 best stocks under $11 in Cathie Wood’s portfolio. If you want to read our detailed analysis of Wood’s history, investment philosophy, and hedge fund performance, go directly to the 10 Best Stocks Under $11 in Cathie Wood’s Portfolio.
5. Sema4 Holdings Corp. (NASDAQ:SMFR)
ARK Investment Management Stake Value: $64,214,000
Percentage of ARK Investment Management’s 13F Portfolio: 0.11%
Number of Hedge Fund Holders: N/A
Price per Share as of Nov. 5, 2021: $8.56
Sema4 Holdings Corp. (NASDAQ:SMFR) is an AI-driven genomic and clinical data intelligence platform company. ARK Investment Management holds more than 4.58 million shares in the firm worth over $64.21 million, making it the company’s most significant stakeholder.
On October 8, BTIG analyst Mark Massaro initiated coverage of Sema4 Holdings, rating the stock as “Buy” and gave a price objective of $12 price.
4. HUYA Inc. (NYSE:HUYA)
ARK Investment Management Stake Value: $56,203,000
Percentage of ARK Investment Management’s 13F Portfolio: 0.1%
Number of Hedge Fund Holders: 11
Price per Share as of Nov. 5, 2021: $8.38
Catherine D. Wood’s ARK Investment Management fund is one of HUYA Inc.’s (NYSE:HUYA) most significant stakeholder.
On October 28, Goldman Sachs analyst Piyush Mubayi reiterated coverage of HUYA, with a “Sell” rating and gave a price target of $9.
3. Enlivex Therapeutics Ltd. (NASDAQ:ENLV)
ARK Investment Management Stake Value: $4,582,000
Percentage of ARK Investment Management’s 13F Portfolio: 0.01%
Number of Hedge Fund Holders: 2
Price per Share as of Nov. 5, 2021: $8.72
Enlivex Therapeutics Ltd. (NASDAQ:ENLV), a clinical-stage immunotherapy startup, has obtained notice of authorization from the Israeli Patent Office for a new patent application covering the company’s immunotherapy product candidate Allocetra.
In the second quarter, Cathie Wood’s ARK Investment Management raised its position in Enlivex Therapeutics Ltd. by 9% to 514,807 shares, accounting for just over 0.01% of the overall portfolio. At the end of the second quarter of 2021, 2 hedge funds in the database of Insider Monkey held stakes worth $6.32 million in Enlivex Therapeutics Ltd. (NASDAQ:ENLV), the same as in the preceding quarter worth $8.50 million.
2. Joby Aviation, Inc. (NYSE:JOBY)
ARK Investment Management Stake Value: $11,885,000
Percentage of ARK Investment Management’s 13F Portfolio: 0.02%
Number of Hedge Fund Holders: N/A
Price per Share as of Nov. 5, 2021: $9.96
In the second quarter, Cathie Wood increased her stake in aircraft manufacturing company Joby Aviation, Inc. (NYSE:JOBY) by 2547%, and her 0.02% stake in the company is now worth about $11.89 million.
In September, Morgan Stanley analyst Kristine Liwag initiated coverage of Joby Aviation, rating the stock as an “Overweight” and gave a price target of $16.
Among the hedge funds being tracked by Insider Monkey, 683 Capital Partners is a leading shareholder in Joby Aviation, Inc. (NYSE:JOBY), with 5.44 million shares worth more than $54.34 million.
1. Blade Air Mobility, Inc. (NASDAQ:BLDE)
ARK Investment Management Stake Value: $41,299,000
Percentage of ARK Investment Management’s 13F Portfolio: 0.07%
Number of Hedge Fund Holders: 11
Price per Share as of Nov. 5, 2021: $10.10
Blade Air Mobility, Inc. (NASDAQ:BLDE) is a worldwide air mobility platform powered by technology. ARK Investment Management added this stock to its portfolio in the second quarter by buying 3.93 million shares. In addition, blade Air Mobility paid $23 million for Trinity Air Medical, with the possibility of further contingent consideration dependent on the accomplishment of specific EBITDA growth objectives over the next three years.
On September 27, Oppenheimer analyst Jason Helfstein initiated coverage of Blade Air Mobility, rating it as “Outperform,” and gave a price target of $14.
At the end of the second quarter of 2021, 11 hedge funds in the database of Insider Monkey held stakes worth $141.75 million in Blade Air Mobility, up from 1 in the previous quarter worth $ 395,000.
You can also take a peek at 10 Best Stocks Under $10 According to Billionaire Daniel Och’s OZ Management and 10 Best Stocks to Buy According to Peter Lewis’ LFL Advisers